Frontiers in Immunology (Jan 2022)
Common Variable Immunodeficiency Disorders as a Model for Assessing COVID-19 Vaccine Responses in Immunocompromised Patients
- Rohan Ameratunga,
- Rohan Ameratunga,
- Rohan Ameratunga,
- See-Tarn Woon,
- See-Tarn Woon,
- Richard Steele,
- Richard Steele,
- Klaus Lehnert,
- Klaus Lehnert,
- Euphemia Leung,
- Euphemia Leung,
- Emily S. J. Edwards,
- Anna E. S. Brooks,
- Anna E. S. Brooks
Affiliations
- Rohan Ameratunga
- Department of Clinical Immunology, Auckland Hospital, Auckland, New Zealand
- Rohan Ameratunga
- Department of Virology and Immunology, Auckland Hospital, Auckland, New Zealand
- Rohan Ameratunga
- Department of Molecular Medicine and Pathology, School of Medicine, Faculty of Medical and Health Sciences, University of Auckland, Auckland, New Zealand
- See-Tarn Woon
- Department of Virology and Immunology, Auckland Hospital, Auckland, New Zealand
- See-Tarn Woon
- Department of Molecular Medicine and Pathology, School of Medicine, Faculty of Medical and Health Sciences, University of Auckland, Auckland, New Zealand
- Richard Steele
- Department of Virology and Immunology, Auckland Hospital, Auckland, New Zealand
- Richard Steele
- Department of Respiratory Medicine, Wellington Hospital, Wellington, New Zealand
- Klaus Lehnert
- School of Biological Sciences, University of Auckland, Auckland, New Zealand
- Klaus Lehnert
- Maurice Wilkins Centre, School of Biological Sciences, University of Auckland, Auckland, New Zealand
- Euphemia Leung
- Maurice Wilkins Centre, School of Biological Sciences, University of Auckland, Auckland, New Zealand
- Euphemia Leung
- Auckland Cancer Society Research Centre, School of Medicine, Faculty of Medical and Health Sciences, University of Auckland, Auckland, New Zealand
- Emily S. J. Edwards
- Allergy and Clinical Immunology Laboratory, Department of Immunology and Pathology, Central Clinical School, Monash University, Melbourne, VIC, Australia
- Anna E. S. Brooks
- School of Biological Sciences, University of Auckland, Auckland, New Zealand
- Anna E. S. Brooks
- Maurice Wilkins Centre, School of Biological Sciences, University of Auckland, Auckland, New Zealand
- DOI
- https://doi.org/10.3389/fimmu.2021.798389
- Journal volume & issue
-
Vol. 12
Abstract
No abstracts available.Keywords
- COVID-19
- SARS-CoV-2
- CVID - common variable immunodeficiency disorders
- vaccine responses
- antibody deficiency
